The mifepristone/temozolomide combination produced a sharply lower expression of VEGF, CD31, P-gp, and MGMT compared to the other groups with implanted cancer cells, including the untreated animals and those given mifepristone or temozolomide alone. This evidence concerns the gene PGP and cancer.